BCL2 and cancer: Progress made in the past decades in understanding how the BCL-2 family of proteins controls mitochondrial integrity and survival in malignant and non-malignant cells has provided an unprecedented opportunity to target this pathway using BH3 mimetics for efficacious cancer treatment.